Proposed Data Collections Submitted for Public Comment and Recommendations, 73006-73007 [E5-7038]
Download as PDF
<![CDATA[
73006
Federal Register / Vol. 70, No. 235 / Thursday, December 8, 2005 / Notices
1. First Federal Bancorp, Columbia,
Mississippi; to become a bank holding
company upon the conversion of its
wholly-owned thrift subsidiary, First
Federal Bank for Savings, Columbia,
Mississippi, to a state nonmember bank,
to be known as First Southern Bank,
Columbia, Mississippi.
Board of Governors of the Federal Reserve
System, December 5, 2005.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E5–7060 Filed 12–7–05; 8:45 am]
BILLING CODE 6210–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Advisory Committee on
Blood Safety and Availability
Department of Health and
Human Services, Office of the Secretary.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services is hereby giving notice that the
Advisory Committee on Blood Safety
and Availability (ACBSA) will hold a
meeting. The meeting will be open to
the public.
DATES: The meeting will take place
Thursday, January 5, 2006 and Friday,
January 6, 2006 from 9 a.m. to 5 p.m.
ADDRESSES: Marriott Crystal Gateway,
1700 Jeff Davis Highway, Arlington, VA
22202.
FOR FURTHER INFORMATION CONTACT: Jerry
A. Holmberg, PhD, Executive Secretary,
Advisory Committee on Blood Safety
and Availability, Office of Public Health
and Science, Department of Health and
Human Services, 1101 Wootton
Parkway, Room 250, Rockville, MD
20852, (240) 453–8809, FAX (240) 453–
8456, e-mail
jholmberg@osophs.dhhs.gov.
SUPPLEMENTARY INFORMATION: The
ACBSA will meet to review progress
and solicit additional input regarding
numerous recommendations made
during the past year. Additionally, the
Committee will discuss strategies for
vigilant detection and management of
emerging or re-emerging infectious and
non-infectious events of transfusion
since it is a necessary first step toward
the goal of reducing the risk of
transfusion-transmitted diseases as well
as disease transmission through other
vital products such as bone marrow,
SUMMARY:
VerDate Aug<31>2005
16:29 Dec 07, 2005
Jkt 208001
progenitor cells, tissues, and organs.
The Committee will also be asked to
review current literature and hear
subject matter experts on the H5NI
avian flu virus and provide
recommendations for preparations
which should be considered for the
nation’s blood supply if a pandemic
influenza or similar pandemic event
occurs. Recommendations on the impact
of a pandemic on the availability of
blood, organs, and other tissue will be
requested.
Public comment will be solicited at
the meeting and will be limited to five
minutes per speaker. Anyone planning
to comment is encouraged to contact the
Executive Secretary at his/her earliest
convenience. Those who wish to have
printed material distributed to Advisory
Committee members should submit
thirty (30) copies to the Executive
Secretary prior to close of business
January 3, 2006. Likewise, those who
wish to utilize electronic data projection
to the Committee must submit their
materials to the Executive Secretary
prior to close of business January 3,
2006.
Jerry A. Holmberg,
Executive Secretary, Advisory Committee on
Blood Safety and Availability.
[FR Doc. E5–7084 Filed 12–7–05; 8:45 am]
BILLING CODE 4150–41–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–06–0009]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–4766 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Disease Surveillance
Program—I. Case Reports—Revision—
(NCID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Formal surveillance of 18 separate
reportable diseases has been ongoing to
meet the public demand and scientific
interest in accurate, consistent,
epidemiologic data. These ongoing
disease reports include: Active Bacterial
Core Surveillance (ABCs), CreutzfeldtJakob Disease (CJD), Cyclospora,
Dengue, Hantavirus, Idiopathic CD4+Tlymphocytopenia, Kawasaki Syndrome,
Legionellosis, Lyme disease, Malaria,
Plague, Q Fever, Reye Syndrome, Tickborne Rickettsial Disease, Trichinosis,
Tularemia, Typhoid Fever, and Viral
Hepatitis. Tularemia is a new addition
to this submission. Case report forms
from state and territorial health
departments enable CDC to collect
demographic, clinical, and laboratory
characteristics of cases of these diseases.
This information is used to direct
epidemiologic investigations, identify
and monitor trends in reemerging
infectious diseases or emerging modes
of transmission, to search for possible
causes or sources of the diseases, and
develop guidelines for prevention and
treatment. The data collected will also
be used to recommend target areas most
in need of vaccinations for selected
diseases and to determine development
of drug resistance.
Because of the distinct nature of each
of the diseases, the number of cases
reported annually is different for each.
There is no cost to respondents other
than their time.
E:\FR\FM\08DEN1.SGM
08DEN1
73007
Federal Register / Vol. 70, No. 235 / Thursday, December 8, 2005 / Notices
ESTIMATE OF ANNUALIZED BURDEN TABLE
Number of
respondents
Form
Number of
responses per
respondent
Total
responses
Hrs/response
Total burden
ABCs ....................................................................................
CJD ......................................................................................
Cyclospora ...........................................................................
Dengue Case Investigation ..................................................
Hantavirus Pulmonary Syndrome ........................................
Idiopathic CD4+T-lymphocytopenia .....................................
Kawasaki Syndrome ............................................................
Legionellosis Case Report ...................................................
Lyme Disease Report ..........................................................
Malaria Case Surveillance Report .......................................
Plague Case Investigation Report .......................................
Q Fever ................................................................................
Reye’s Syndrome Case Surveillance Report ......................
Tick-borne Rickettsial Disease Case Report .......................
Trichinosis Surveillance Case Report ..................................
Tularemia .............................................................................
Typhoid Fever Surveillance Report .....................................
Viral Hepatitis Case Record ................................................
329
20
55
55
40
10
55
23
52
55
55
55
50
55
55
55
55
55
21
2
10
182
3
2
8
11.7
261
20
0.20
1
1
18
0.70
2.2
7
200
6909
40
550
10,010
120
20
440
269
20,020
1,100
11
55
50
990
39
121
385
11,000
10/60
20/60
15/60
15/60
20/60
10/60
15/60
20/60
5/60
15/60
20/60
10/60
20/60
10/60
20/60
20/60
20/60
25/60
1152
13
138
2,503
40
3
110
90
1,668
275
4
9
17
165
13
40
128
4,583
Total ..............................................................................
........................
........................
........................
........................
10,950
Dated: December 2, 2005.
Joan Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E5–7038 Filed 12–7–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–06–06AK]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–4766 or send
comments to Seleda Perryman, CDC
Assistant Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
VerDate Aug<31>2005
16:29 Dec 07, 2005
Jkt 208001
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Collection of Customer Survey Data
Pertaining to the CDC Web site—New—
National Center for Health Marketing
(NCHM), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Executive Order 12862 directs
agencies that provide significant
services directly to the public to survey
customers to determine the kind and
quality of services they need and their
level of satisfaction with existing
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
services. The Centers for Disease
Control and Prevention (CDC), National
Center for Health Marking (NCHM),
seeks to obtain approval to conduct
customer satisfaction surveys and
usability tests of the CDC Web site,
https://www.cdc.gov on an ongoing basis.
By collecting customer satisfaction and
Web site usability information, CDC will
be enabled to serve, and respond to, the
ever-changing demands of website
users. These users include individuals
(patients, educators, students, etc.),
interested communities, partners,
healthcare providers, and businesses.
Survey information will augment
current Web content, delivery, and
design research which is used to
understand the Web user, and more
specifically, the CDC user community.
Primary objectives are to ensure: (1)
CDC’s Web site meets its customer
needs and (2) the Web site meets the
wants, preferences, and needs of its
target audiences. Findings will help to:
(1) Understand the user community and
how to better serve Internet users; (2)
discover areas requiring improvement in
either content or delivery; (3) determine
how to align Web offerings with
identified user need(s); and (4) explore
methods for offering, presenting and
delivering information most effectively.
There are no costs to respondents other
than their time.
E:\FR\FM\08DEN1.SGM
08DEN1
]]>Agencies
[Federal Register Volume 70, Number 235 (Thursday, December 8, 2005)]
[Notices]
[Pages 73006-73007]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E5-7038]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-06-0009]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-4766
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
National Disease Surveillance Program--I. Case Reports--Revision--
(NCID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Formal surveillance of 18 separate reportable diseases has been
ongoing to meet the public demand and scientific interest in accurate,
consistent, epidemiologic data. These ongoing disease reports include:
Active Bacterial Core Surveillance (ABCs), Creutzfeldt-Jakob Disease
(CJD), Cyclospora, Dengue, Hantavirus, Idiopathic CD4+T-
lymphocytopenia, Kawasaki Syndrome, Legionellosis, Lyme disease,
Malaria, Plague, Q Fever, Reye Syndrome, Tick-borne Rickettsial
Disease, Trichinosis, Tularemia, Typhoid Fever, and Viral Hepatitis.
Tularemia is a new addition to this submission. Case report forms from
state and territorial health departments enable CDC to collect
demographic, clinical, and laboratory characteristics of cases of these
diseases. This information is used to direct epidemiologic
investigations, identify and monitor trends in reemerging infectious
diseases or emerging modes of transmission, to search for possible
causes or sources of the diseases, and develop guidelines for
prevention and treatment. The data collected will also be used to
recommend target areas most in need of vaccinations for selected
diseases and to determine development of drug resistance.
Because of the distinct nature of each of the diseases, the number
of cases reported annually is different for each. There is no cost to
respondents other than their time.
[[Page 73007]]
Estimate of Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Number of
Form Number of responses per Total Hrs/response Total burden
respondents respondent responses
----------------------------------------------------------------------------------------------------------------
ABCs............................ 329 21 6909 10/60 1152
CJD............................. 20 2 40 20/60 13
Cyclospora...................... 55 10 550 15/60 138
Dengue Case Investigation....... 55 182 10,010 15/60 2,503
Hantavirus Pulmonary Syndrome... 40 3 120 20/60 40
Idiopathic CD4+T-lymphocytopenia 10 2 20 10/60 3
Kawasaki Syndrome............... 55 8 440 15/60 110
Legionellosis Case Report....... 23 11.7 269 20/60 90
Lyme Disease Report............. 52 261 20,020 5/60 1,668
Malaria Case Surveillance Report 55 20 1,100 15/60 275
Plague Case Investigation Report 55 0.20 11 20/60 4
Q Fever......................... 55 1 55 10/60 9
Reye's Syndrome Case 50 1 50 20/60 17
Surveillance Report............
Tick-borne Rickettsial Disease 55 18 990 10/60 165
Case Report....................
Trichinosis Surveillance Case 55 0.70 39 20/60 13
Report.........................
Tularemia....................... 55 2.2 121 20/60 40
Typhoid Fever Surveillance 55 7 385 20/60 128
Report.........................
Viral Hepatitis Case Record..... 55 200 11,000 25/60 4,583
-----------------
Total....................... .............. .............. .............. .............. 10,950
----------------------------------------------------------------------------------------------------------------
Dated: December 2, 2005.
Joan Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E5-7038 Filed 12-7-05; 8:45 am]
BILLING CODE 4163-18-P
